Evolution of a novel orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease.

Amour, Augustin and Barton, Nick and Cooper, Anthony W.J. and Inglis, Graham and Jamieson, Craig and Luscombe, Christopher N. and Perez, David and Peace, Simon and Rowland, Paul and Tame, Chris and Uddin, Sorif and Vitulli, Giovanni and Wellaway, Natalie (2016) Evolution of a novel orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease. Journal of Medicinal Chemistry. ISSN 0022-2623

[thumbnail of Amour-etal-JMC2016-Novel-orally-bioavailable-series-of-PI3Kδ-inhibitors]
Preview
 Text (Amour-etal-JMC2016-Novel-orally-bioavailable-series-of-PI3Kδ-inhibitors)
Amour_etal_JMC2016_Novel_orally_bioavailable_series_of_PI3K_inhibitors.pdf
Accepted Author Manuscript
Download (1MB)| Preview

    Abstract

    A four step process of high quality modelling of existing data, deconstruction, identification of replacement cores and an innovative synthetic re-growth strategy led to the rapid discovery of a novel oral series of PI3K δ inhibitors with promising selectivity and excellent in vivo characteristics.

    ORCID iDs

    Amour, Augustin, Barton, Nick, Cooper, Anthony W.J., Inglis, Graham, Jamieson, Craig ORCID logoORCID: https://orcid.org/0000-0002-6567-8272, Luscombe, Christopher N., Perez, David, Peace, Simon, Rowland, Paul, Tame, Chris, Uddin, Sorif, Vitulli, Giovanni and Wellaway, Natalie;
    • Item type:Article
      ID code:57124
      Dates:
      Date
      Event
      18 July 2016
      Published
      18 July 2016
      Published Online
      18 July 2016
      Accepted
      Notes:This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see [insert ACS Articles on Request author-directed link to Published Work, see https://dx.doi.org10.1021/acs.jmedchem.6b00799
      Keywords:PI3Kδ inhibitors, respiratory disease, bioavailability, deconstruction, hinge-binding groups, optimisation, indazole core, physicochemical properties, pharmacokinetic properties, Pharmacy and materia medica, Drug Discovery, Molecular Medicine
      Subjects:Medicine > Pharmacy and materia medica
      Department:Faculty of Science > Pure and Applied Chemistry
      Depositing user: Pure Administrator
      Date deposited:27 Jul 2016 08:33
      Last modified:19 Jul 2021 01:48
      URI:https://strathprints.strath.ac.uk/id/eprint/57124
    CORE (COnnecting REpositories)